Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Mindset reports first preclinical psychedelic benchmark data from COPE program

June 15, 2021

Roche synthesizes muscarinic M4 receptor PAMs

June 15, 2021

Rohto initiates phase I/II study of UDI-001 in pediatric patients with cerebral palsy

June 14, 2021

Ossianix patents TfR1-targeting antibodies for neurodegeneration

June 14, 2021

Sunshine Lake Pharma presents new antimigraine drugs

June 14, 2021

Myelin renewal reverses AD cognitive dysfunction in mice

June 11, 2021

Sovateltide slows down the progression of Alzheimer's disease in phase II study

June 11, 2021

Spark Therapeutics patents compositions for secretable protein-induced immune tolerization

June 11, 2021

Stress sensor DJ-1 can heighten or dampen inflammation

June 9, 2021

Promising interim phase I and II data for BION-1301 in patients with IgA nephropathy

June 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...